Citizens Jmp Has Lowered Expectations for Addus HomeCare (NASDAQ:ADUS) Stock Price

Key Points

• Citizens Jmp lowered its price target on Addus from $150 to $142 but kept a "market outperform" rating, implying roughly a 47% upside from the stock's current price.
• Q1 results: Addus reported $1.62 EPS (above the $1.52 estimate) while revenue of $363.5M slightly missed expectations, with revenue up 7.7% year-over-year and shares trading down to about $96.42.
• Market sentiment: Analysts' consensus is a "Moderate Buy" with an average price target of $132.33, while insiders have sold ~16,788 shares in the past 90 days (insiders own 4.5%), which could influence investor outlook.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) had its target price lowered by investment analysts at Citizens Jmp from $150.00 to $142.00 in a report issued on Wednesday,Benzinga reports. The firm presently has a "market outperform" rating on the stock. Citizens Jmp's target price suggests a potential upside of 47.27% from the stock's current price.

A number of other brokerages have also recently issued reports on ADUS. Weiss Ratings restated a "hold (c+)" rating on shares of Addus HomeCare in a report on Wednesday, January 21st. KeyCorp restated an "overweight" rating on shares of Addus HomeCare in a report on Wednesday, February 25th. Wall Street Zen cut shares of Addus HomeCare from a "strong-buy" rating to a "buy" rating in a report on Saturday, March 21st. Royal Bank Of Canada restated an "outperform" rating and set a $139.00 price objective on shares of Addus HomeCare in a report on Wednesday, February 25th. Finally, Truist Financial set a $135.00 price objective on shares of Addus HomeCare and gave the company a "buy" rating in a report on Wednesday, January 7th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $132.33.

Addus HomeCare Trading Down 2.0%

Shares of NASDAQ:ADUS traded down $2.02 during trading on Wednesday, hitting $96.42. 31,016 shares of the company's stock were exchanged, compared to its average volume of 240,060. Addus HomeCare has a 1-year low of $90.89 and a 1-year high of $124.43. The firm has a 50-day moving average price of $98.43 and a two-hundred day moving average price of $107.69. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.11. The firm has a market cap of $1.80 billion, a P/E ratio of 17.81, a PEG ratio of 1.38 and a beta of 0.92.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, May 4th. The company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.52 by $0.10. The company had revenue of $363.50 million during the quarter, compared to analysts' expectations of $366.41 million. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.95%. Addus HomeCare's revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.42 EPS. Equities analysts predict that Addus HomeCare will post 6.21 earnings per share for the current year.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 4,988 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total value of $533,616.24. Following the transaction, the chief executive officer owned 185,514 shares of the company's stock, valued at approximately $19,846,287.72. The trade was a 2.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Brian Poff sold 2,041 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total transaction of $218,346.18. Following the completion of the transaction, the executive vice president directly owned 64,512 shares in the company, valued at approximately $6,901,493.76. The trade was a 3.07% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 16,788 shares of company stock valued at $1,785,633. 4.50% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Global Retirement Partners LLC lifted its stake in Addus HomeCare by 395.7% in the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company's stock valued at $25,000 after buying an additional 186 shares in the last quarter. Larson Financial Group LLC lifted its position in shares of Addus HomeCare by 133.3% in the third quarter. Larson Financial Group LLC now owns 238 shares of the company's stock worth $28,000 after purchasing an additional 136 shares in the last quarter. Acumen Wealth Advisors LLC bought a new stake in shares of Addus HomeCare in the fourth quarter worth $29,000. Arax Advisory Partners lifted its position in shares of Addus HomeCare by 95.8% in the fourth quarter. Arax Advisory Partners now owns 280 shares of the company's stock worth $30,000 after purchasing an additional 137 shares in the last quarter. Finally, Private Trust Co. NA lifted its position in shares of Addus HomeCare by 65.5% in the fourth quarter. Private Trust Co. NA now owns 283 shares of the company's stock worth $30,000 after purchasing an additional 112 shares in the last quarter. Institutional investors own 95.35% of the company's stock.

Addus HomeCare Company Profile

Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.

The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.